Latest Blog Posts Tagged "Alpha-Synuclein"
July 17, 2018
A promising approach to stopping Parkinson's is to target the rogue protein alpha-synuclein. We share the latest on six trials testing therapies with this goal.
December 11, 2017
Dr. Dolhun discusses constipation, a common non-motor symptom in Parkinson's, and ways to treat it.
October 24, 2017
In a recent review paper, top Parkinson's experts outline unanswered questions hindering development of treatments against key protein alpha-synuclein.
July 10, 2017
Five projects targeting alpha-synuclein are in clinical trials with more preparing for testing.
June 29, 2017
MJFF scientist speaks to "Nature Reviews Drug Discovery" about alpha-synuclein research progress in Parkinson's disease.
June 22, 2017
MJFF-funded researchers published on a connection between the key Parkinson's protein alpha-synuclein and the immune system. This finding may point to a new way to stop or slow disease.
May 02, 2017
A new study builds on the theory that PD could start in the gut, rather than the brain.
April 13, 2017
Researchers haven't yet determined the optimal location or method to sample alpha-synuclein. Learn how MJFF's Systemic Synuclein Sampling Study is hoping to change this.
March 20, 2017
A recently published study has revealed differences in gut bacteria in those with Parkinson's disease based on their medications and geographic locations, adding to our growing knowledge.
February 14, 2017
This study is a major step for PD research as it is the first drug trial where one's genetic information determines eligibility and is testing a potential therapy to slow or stop disease progression.